Clinical Trial Update: GSK1349572 Drug Interaction Study With Fosamprenavir/Ritonavir [Phase 1]

View source ↗

Summary

This is a Phase 1 drug interaction study to evaluate how dolutegravir (GSK1349572) interacts with the HIV protease inhibitor boosting regimen fosamprenavir/rito…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Lexiva (Fosamprenavir)
• Norvir (ritonavir)
• Tivicay (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: Infections, Human Immunodeficiency Virus and Herpesviridae | Phase 1 | Status: COMPLETED